Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2013 May 11;40(8):4843–4849. doi: 10.1007/s11033-013-2582-7

Polymorphic genetic variation in immune system genes: a study of two populations of Espirito Santo, Brazil

Raquel Spinassé Dettogni 1, Ricardo Tristão Sá 2, Thaís Tristão Tovar 1, Iúri Drumond Louro 1,
PMCID: PMC7088621  PMID: 23666056

Abstract

Mapping single nucleotide polymorphisms (SNPs) in genes potentially involved in immune responses may help understand the pathophysiology of infectious diseases in specific geographical regions. In this context, we have aimed to analyze the frequency of immunogenetic markers, focusing on genes CD209 (SNP -336A/G), FCγRIIa (SNP -131H/R), TNF-α (SNP -308A/G) and VDR (SNP Taq I) in two populations of the Espirito Santo State (ES), Brazil: general and Pomeranian populations. Peripheral blood genomic DNA was extracted from one hundred healthy individuals of the general population and from 59 Pomeranians. Polymorphic variant identification was performed by polymerase chain reaction-restriction fragment length polymorphism (PCR–RFLP). SNP genotype frequencies were in Hardy–Weinberg Equilibrium. There was no statistically significant difference in allelic and genotypic distributions between the two populations studied. Statistically significant differences were observed for SNP genotype distribution in genes CD209, TNF-α and VDR when comparing the ES populations with other Brazilian populations. This is the first report of CD209, FcγRIIa, TNF-α and VDR allelic frequencies for the general and Pomeranian populations of ES.

Keywords: Polymorphisms, Immune system, Infectious diseases, Espirito Santo-Brazil

Introduction

Small genetic variations such as SNPs can influence gene expression and change protein structure or function. SNPs located in the promoter or other regulatory regions may affect gene transcription and alter variability in the immune response. The presence of certain alleles may contribute to the susceptibility or host resistance for different infectious diseases caused by viruses [1], bacteria [2] and protozoa [35].

SNPs in genes CD209, FcγRIIa, TNF-α and VDR affect the immune response for various infections [1, 68]. Gene and protein nomenclature are shown in Table 1.

Table 1.

SNPs associated with response to infectious diseases

Gene Protein SNP rs number Reference allele Variant allele
CD209 Dendritic cell-specific −336 A/G 4804803 A G
FcγRIIa Fc gama −131 H/R 1801274 A G
TNF-α Tumor necrosis factor −308 A/G 1800629 G A
VDR Vitamin D receptor Taq I 731236 T C

Dendritic cell-specific ICAM-3 grabbing non-integrin (DC-SING, encoded by CD209) is mainly expressed in dendritic cells (DC) and plays an important role in some infectious diseases [911]. DCs can be targets for pathogens, in an attempt to impair the initial immune response in early infection [12]. Among SNPs in the CD209, the guanine (G) to adenine (A) transition at position 2336 within the CD209 gene promoter (SNP -336 A/G) has been suggested to affect transcriptional activity of DC-SIGN [8]. Association studies have been performed between CD209 gene polymorphisms and pathogens: viruses such as human immunodeficiency virus-1 (HIV-1), hepatitis C virus (HCV), cytomegalovirus, Ebola virus and SARS-coV; bacteria such as Mycobacterium tuberculosis and parasites such as Leishmania and Schistosoma mansoni [1317]. SNP -336A/G has been associated with the susceptibility to HIV [18], M. tuberculosis [19], HCV [20], and dengue [8].

Fcγ leukocyte receptors are essential for the immune defense against pathogens. Antibody binding to the Fc-receptors causes important biological consequences, e.g. antibody dependent cell-mediated cytotoxicity or inhibition and phagocytosis [21]. FcγRIIa has two co-dominantly expressed alleles, R131 (G at position 494) and H131 (A at position 494), which differ in their ability to bind immunoglobulin G (IgG) subclasses. Cells expressing H131 bind more efficiently to IgG2 and IgG3 than those expressing the R131 variant [22]. This SNP has been associated with susceptibility and severity of some infectious disease such as meningococcal disease, Streptococcus pneumoniae infections, dengue fever and HIV infection [1, 2325]. RR genotype seems to be associated with protection against intracellular pathogen infections [2, 26, 27].

TNF-α is a pleiotropic pro-inflammatory cytokine, with effects on apoptosis and activation of target cells involved in the amplification of immunological cellular processes [28]. Among several TNF-α gene polymorphisms, the SNP located at nucleotide position 308 (G or A) has been shown to directly affect TNF-α expression [29]. The AA genotype has been significantly associated with higher TNF-α production and in some cases with increased morbidity and mortality in sepsis, malaria, chronic obstructive pulmonary disease (COPD), leishmaniosis, systemic lupus erythematosus (SLE), type 1 autoimmune hepatitis and other immune mediated disorders (asthma and contact dermatitis) [3034].

The vitamin D receptor (VDR) mediates the immunoregulatory effects of the hormonal form of vitamin D, which includes activating monocytes, stimulating cellular immune responses, suppressing immunoglobulin production and lymphocyte proliferation [35]. The TT genotype of VDR Taq I SNP (substitution of a thymine (T) for a cytosine (C) at position 352) [36] has been recently associated with tuberculoid leprosy, enhanced clearance of hepatitis B infection and resistance to pulmonary tuberculosis [37, 38].

SNP frequency characterization of genes encoding immune mediators may aid in the creation of alternative methods for diagnosis, vaccine development or more effective therapies according to the population genetic profile. SNP frequencies are population specific, reason because we decided to characterize the general population and the Pomeranian subpopulation of ES, Brazil, for 4 SNPs in immune system genes.

Materials and methods

This study was approved by the Research Ethics Committee of the Federal University of ES and all patients signed an informed consent (Protocol n°190/11).

Sample

Five milliliters (ml) of peripheral blood were collected from 100 healthy volunteers of the ES general population. As for the 59 healthy Pomeranian volunteers of Santa Maria de Jetibá, ES, 3–5 peripheral blood drops were collected on FTA® Elute Cards (Whatman, USA).

SNP genotyping

Genomic DNA was isolated using phenol/chloroform extraction or following FTA® Elute Card manufacturer’s recommendations (Whatman, USA). CD209, FcγRIIa, TNF-α and VDR alleles were detected by PCR–RFLP. Primer sequences, restriction enzymes and conditions are shown in Table 2.

Table 2.

Primer sequences and RFLP conditions

Gene SNP Primer sequence Product size Restriction enzyme Digestion pattern Reference
CD209 −336 A/G (rs4804803)

5′-CAGAGCATG GACAGG GAGCAAG-3′

5′- GGATGTACGTCTGCAGTGTG-3′

150 bp MscI

Allele G—19 bp + 131pb

Allele A—150 bp

[8]
FcγRIIa −131 H/R (rs1801274)

5′- GGAAAATCCAGAAATTCTCGC-3′

5′- CAACAGCCTGACTACCTATTACGCGGG-3′

366 bp BstUI

Allele H—343 bp

Allele R—322 bp

[39]
TNF-α −308 A/G (rs1800629)

5′- AGGCAATAGGTTTTGAGGGCCAT-3′

5′- TCCTCCCTGCTCCGATTCCG-3′

107 bp NcoI

Allele A—107 bp

Allele G—87 bp + 20 bp

[40]
VDR Taq I (rs731236)

5′-CAGAGCATGGACAGGGAGCAAG-3′

5′-GGATGTACGTCTGCAGTGTG-3′

340 bp TaqI

Allele T—340 bp

Allele C—293 bp + 47pb

[41]

bp base pairs

Statistical analysis

SNP allele and genotype frequencies were determined by direct counting. P values <0.05 were considered statistically significant. Chi square test was used to determine whether a genotype was at HWE, using Chi square HWE equilibrium test calculator for biallelic markers (http://www.genes.org.uk/software/hardy-weinberg.shtml). Fisher’s exact test was performed using Graphpad Prism ® version 5.0 (www.graphpad.com).

Results

Representative genotyping results are shown in Figs. 1, 2, 3 and 4.

Fig. 1.

Fig. 1

CD209 genotypes. a amplified DNA products. b MscI digestion of PCR products. bp base pairs; Ladder: 25 bp molecular weight marker

Fig. 2.

Fig. 2

FcγRIIa genotypes. a amplified DNA products and BstUI PCR product digestion. bp base pairs; Ladder: 25 bp molecular weight marker

Fig. 3.

Fig. 3

TNF-α genotypes. a amplified DNA products. b NcoI digestion of PCR products. bp base pairs; Ladder: 25 bp molecular weight marker

Fig. 4.

Fig. 4

VDR genotypes. a amplified DNA products. b Taq I digestion of PCR products. bp base pairs; Ladder: 25 bp molecular weight marker

SNP allele and genotype frequencies for genes CD209, FcγRIIa, TNF-α and VDR in the Pomeranian and general populations of ES are given in Table 3. All polymorphisms were at HWE equilibrium among Pomeranian and non-Pomeranian individuals (p > 0.05, Table 4). Genotype and allele frequencies were not significantly different between the two populations (p > 0.05, Table 5).

Table 3.

Allele and genotype SNP frequencies

Allele/genotype General population (n = 100) Pomeranian population (n = 59)
CD209: −336 A/G
A 62.5 (125) 80.5 (95)
G 37.5 (75) 19.5 (23)
AA 61 (61) 66.1 (39)
AG 36 (36) 28.8 (17)
GG 3 (3) 5.1 (3)
FcγRIIa: −131 H/R
H 48 (96) 50.8 (60)
R 52 (104) 49.2 (58)
HH 21 (21) 22 (13)
HR 54 (54) 57.6 (34)
RR 25 (25) 20.4 (12)
TNF-α: −308 A/G
A 20 (40) 17.8 (21)
G 80 (160) 82.2 (97)
AA 5 (5) 3.4 (2)
AG 30 (30) 28.8 (17)
GG 65 (65) 67.8 (40)
VDR: Taq I
T 63.5 (127) 66.1 (78)
C 36.5 (73) 33.9 (40)
TT 41 (41) 44.07 (26)
TC 45 (45) 44.07 (26)
CC 14 (14) 11.9 (7)

Numbers in parenthesis represents allele or genotype counts

Table 4.

p- and x2 values for HWE calculations in both populations was performed by x2-test

Gene/SNP X2/p value (General population) X2/p value (pomeranian population)
CD209/−336 A/G 0.72/0.40 0.40/0.53
FcγRIIa/−131 H/R 0.67/0.41 1.38/0.24
TNF-α/−308 A/G 0.39/0.53 0.01/0.92
VDR/Taq I 0.09/0.76 0.02/0.89

Table 5.

Allele and genotype frequencies, p value calculated by Fischer’s exact test

Genotype/Allele p value (General population vs. Pomeranians)
CD209: −336 A/G
A and G 0.32
AA 0.61
AG 0.39
GG 0.67
FcγRIIa: −131 H/R
H and R 0.64
HH 1.0
HR 0.74
RR 0.57
TNF-α: −308 A/G
A and G 0.66
GG 0.86
AG 1.0
AA 1.0
VDR: Taq I
T and C 0.72
TT 0.74
TC 1.0
CC 0.81

Discussion

This study aimed to characterize the general and Pomeranian populations of ES, Brazil as for 4 SNPs in genes important for the immune response to infections.

Allelic frequencies for all SNPs were in HWE equilibrium. There was no statistically significant difference in allelic and genotypic distributions between the two populations. This result confirms data of Stur et al. [42] which reported gene flow between the general and Pomeranian populations of ES.

For each SNP, we analyzed the difference in genotype distribution among ES populations and two other populations of different ethnic groups randomly selected and a population of southeast Brazil (Table 6).

Table 6.

SNPs frequencies in association studies of various ethnic groups (healthy individuals). P values calculated by Fischer’s exact test

SNP Population Sample size Genotype Frequency p value (population of column 2 vs. general population of ES) p value (population of column 2 vs. pomeranian population of ES) Reference
CD209: −336 A/G Taiwanese 120 AA 111 <0.0001* <0.0001* [43]
AG 9 <0.0001* 0.0004*
GG 0 0.1 0.03*
South African 360 AA 137 <0.0001* <0.0001* [19]
AG 156 0.21 0.04*
GG 67 <0.0001* 0.008*
Brazilian (Sao Paulo) 32 AA 18 0.68 0.37 [44]
AG 9 0.52 1.0
GG 5 0.02* 0.12
FcγRIIa: −131 H/R African American 170 HH 44 0.38 0.6 [45]
HR 73 0.1 0.07
RR 53 0.33 0.13
Caucasian 220 HH 69 0.06 0.15
HR 97 0.1 0.08
RR 54 1.0 0.6
Brazilian (Sao Paulo) 48 HH 13 0.41 0.65 [22]
HR 25 0.2 0.7
RR 10 0.68 1.0
TNF-α: −308 A/G Italian 138 GG 109 0.02* 0.1 [6]
GA 29 0.13 0.27
AA 0 0.01* 0.09
American (USA) 235 GG 164 0.44 0.75 [46]
GA 67 0.79 1.0
AA 4 0.13 0.35
Brazilian (Minas Gerais) 43 GG 29 0.85 1.0 [47]
GA 14 0.84 0.83
AA 0 0.32 0.51
VDR: Taq I Vietnamese 247 TT 231 <0.0001* <0.0001* [1]
TC 15 <0.0001* <0.0001*
CC 1 <0.0001* <0.0001*
Indian 143 TT 70 0.24 0.54 [48]
TC 62 0.89 1.0
CC 11 0.13 0.42
Brazilian (Rio de Janeiro) 40 TT 29 0.001* 0.007* [49]
TC 7 0.003* 0.009*
CC 4 0.78 1.0

* Statistically significant values

CD209 gene SNP showed a significant difference in genotype distribution between the ES populations separately, as well as when they were compared with the population of Taiwan and South Africa. Moreover, the GG genotype had a significant difference in distribution between the general ES and Sao Paulo populations.

FcγRIIa SNP genotype distribution was not different among ES populations and other populations analyzed.

Comparing TNF-α SNP genotype frequencies among ES populations and other 3 populations, there was a statistically significant difference in homozygous genotypes distribution between the general ES population and Italians.

VDR SNPs showed a significant difference in genotype distribution among ES populations and populations of Rio de Janeiro and Vietnam.

These variations indicate the need to characterize specific populations for SNP composition in genes important for the immune system in various regions of the world.

The ES state, as well as the entire southeastern Brazil, presents high prevalence of many infectious diseases. Thus, assessing the genetic diversity of immune system components may generate knowledge relevant to the understanding of how the population responds to infectious diseases such as dengue, tuberculosis, hepatitis, malaria, HIV and others.

Acknowledgments

RSD was supported by Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) and Fundação de Amparo à Pesquisa do Espírito Santo (FAPES) scholarships. This work was supported by FAPES.

Contributor Information

Raquel Spinassé Dettogni, Phone: +55-27-3335-7251, FAX: +55-27-3335-7250.

Ricardo Tristão Sá, Phone: +55-27-3334-3500.

Thaís Tristão Tovar, Phone: +55-27-3335-7251, FAX: +55-27-3335-7250.

Iúri Drumond Louro, Phone: +55-27-3335-7251, FAX: +55-27-3335-7250, Email: iurilouro@yahoo.com.

References

  • 1.Loke H, Bethell D, Phuong CXT, et al. Susceptibility to dengue hemorrhagic fever in Vietnam: evidence of an association with variation in the vitamin D receptor and Fcγ receptor IIA genes. Am J Trop Med Hyg. 2002;67:102–106. doi: 10.4269/ajtmh.2002.67.102. [DOI] [PubMed] [Google Scholar]
  • 2.Yee AMF, Phan HM, Zuniga R, et al. Association between FcγRIIa-R131 allotype and bacteremic pneumococcal pneumonia. Clin Infect Dis. 2000;30:25–28. doi: 10.1086/313588. [DOI] [PubMed] [Google Scholar]
  • 3.Aucan C, Traore Y, Tall F, et al. High immunoglobulin G2 (IgG2) and low IgG4 levels are associated with human resistance to Plasmodium falciparum malaria. Infec Immun. 2000;68:1252–1258. doi: 10.1128/IAI.68.3.1252-1258.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Omi K, Ohashi J, Patarapotikul J, et al. Fcγ receptor IIA and IIIB polymorphisms are associated with susceptibility to cerebral malaria. Parasitol Int. 2002;51:361–366. doi: 10.1016/S1383-5769(02)00040-5. [DOI] [PubMed] [Google Scholar]
  • 5.Shi YP, Nahlen BL, Kariuki S, et al. Fcg receptor IIa (CD32) polymorphism is associated with protection of infants against high-density Plasmodium falciparum infection. J Infect Dis. 2001;184:107–111. doi: 10.1086/320999. [DOI] [PubMed] [Google Scholar]
  • 6.Boin F, Zanardini R, Piolo R, et al. Association between G308A tumor necrosis factor alpha gene polymorphism and schizophrenia. Mol Psychiatry. 2001;6:79–82. doi: 10.1038/sj.mp.4000815. [DOI] [PubMed] [Google Scholar]
  • 7.Garcia G, Sierra B, Perez AB, et al. Asymptomatic dengue infection in a Cuban population confirms the protective role of the RR variant of the FcgammaRIIa polymorphism. Am J Trop Med Hyg. 2010;82:1153–1156. doi: 10.4269/ajtmh.2010.09-0353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Sakuntabhai A, Turbpaiboon C, Casademont I, et al. A variant in the CD209 promoter is associated with severity of dengue disease. Nat Genet. 2005;37:507–513. doi: 10.1038/ng1550. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Cambi A, Gijzen K, de Vries JM, et al. The C type lectin DC-SIGN (CD209) is an antigen-uptake receptor for Candida albicans on dendritic cells. Eur J Immunol. 2003;33:532–538. doi: 10.1002/immu.200310029. [DOI] [PubMed] [Google Scholar]
  • 10.Rappocciolo G, Jenkins FJ, Hensler HR, et al. DCSIGN is a receptor for human herpes virus 8 on dendritic cells and macrophages. J Immunol. 2006;176:1741–1749. doi: 10.4049/jimmunol.176.3.1741. [DOI] [PubMed] [Google Scholar]
  • 11.Tassaneetrithep B, Burgess TH, Granelli-Piperno A, et al. DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J Exp Med. 2003;197:823–829. doi: 10.1084/jem.20021840. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Rinaldo CR, Jr, Piazza P. Virus infection of dendritic cells: portal for host invasion and host defense. Trends Microbiol. 2004;12:337–345. doi: 10.1016/j.tim.2004.05.003. [DOI] [PubMed] [Google Scholar]
  • 13.Halary F, Amara A, Lortat-Jacob H, et al. Human cytomegalovirus binding to DC-SIGN is required for dendritic cell infection and target cell trans infection. Immunity. 2002;17:653–664. doi: 10.1016/S1074-7613(02)00447-8. [DOI] [PubMed] [Google Scholar]
  • 14.Klimstra WB, Nangle EM, Smith MS, et al. DC-SIGN and L-SIGN can act as attachment receptors for alphaviruses and distinguish between mosquito cell and mammalian cell-derived viruses. J Virol. 2003;77:12022–12032. doi: 10.1128/JVI.77.22.12022-12032.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Tailleux L, Schwartz O, Herrmann JL, et al. DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells. J Exp Med. 2003;197:121–127. doi: 10.1084/jem.20021468. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Van Kooyk Y, Appelmelk B, Geijtenbeek TB. A fatal attraction: mycobacterium tuberculosis and HIV-1 target DC-SIGN to escape immune surveillance. Trends Mol Med. 2003;9:153–159. doi: 10.1016/S1471-4914(03)00027-3. [DOI] [PubMed] [Google Scholar]
  • 17.Yang ZY, Huang Y, Ganesh L, et al. pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DCSIGN. J Virol. 2004;78:5642–5650. doi: 10.1128/JVI.78.11.5642-5650.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Martin MP, Lederman MM, Hutcheson HB, et al. Association of DC-SIGN promoter polymorphism with increased risk for parenteral, but not mucosal, acquisition of human immunodeficiency virus type 1 infection. J Virol. 2004;78:14053–14056. doi: 10.1128/JVI.78.24.14053-14056.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Barreiro LB, Neyrolles O, Babb CL, et al. Promoter variation in the DC-SIGN-encoding gene CD209 is associated with tuberculosis. PLoS Med. 2006;3:e20. doi: 10.1371/journal.pmed.0030020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Ryan EJ, Dring M, Ryan CM, et al. Variant in CD209 promoter is associated with severity of liver disease in chronic hepatitis C virus infection. Hum Immunol. 2010;71:829–832. doi: 10.1016/j.humimm.2010.05.007. [DOI] [PubMed] [Google Scholar]
  • 21.Van der Pol WL, Van de Winkel JGJ. IgG receptor polymorphisms: risk factors for disease. Immunogenetics. 1998;48:222–232. doi: 10.1007/s002510050426. [DOI] [PubMed] [Google Scholar]
  • 22.Bazilio AP, Viana VST, Toledo R, et al. FcγRIIa polymorphism: a susceptibility factor for immune complex-mediated lupus nephritis in Brazilian patients. Nephrol Dial Transplant. 2004;19:1427–1431. doi: 10.1093/ndt/gfh121. [DOI] [PubMed] [Google Scholar]
  • 23.Brouwer KC, Lal RB, Mirel LB, et al. Polymorphism of Fc receptor IIa for IgG in infants is associated with susceptibility to perinatal HIV-1 infection. AIDS. 2004;18:1187–1194. doi: 10.1097/00002030-200405210-00012. [DOI] [PubMed] [Google Scholar]
  • 24.Platonov AE, Shipulin GA, Vershinina IV, et al. Association of human Fc gamma RIIa (CD32) polymorphism with susceptibility to and severity of meningococcal disease. Clin Infect Dis. 1998;27:746–750. doi: 10.1086/514935. [DOI] [PubMed] [Google Scholar]
  • 25.Yuan FF, Wong M, Pererva N, et al. FcgammaRIIA polymorphisms in Streptococcus pneumoniae infection. Immunol Cell Biol. 2003;81:192–195. doi: 10.1046/j.1440-1711.2003.01158.x. [DOI] [PubMed] [Google Scholar]
  • 26.Bossuyt X, Moens L, Van Hoeyveld E, et al. Coexistence of (partial) immune defects and risk of recurrent respiratory infections. Clin Chem. 2007;53:1124–1130. doi: 10.1373/clinchem.2007.093989. [DOI] [PubMed] [Google Scholar]
  • 27.Cooke G, Aucan C, Walley AJ, et al. Association of Fcgamma receptor IIa (CD32) polymorphism with severe Malaria in West Africa. Am J Trop Hyg. 2003;69:565–568. [PubMed] [Google Scholar]
  • 28.Malinin NL, Boldin MP, Kovalenko AV, et al. MAP3 K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1. Nature. 1997;385:540–544. doi: 10.1038/385540a0. [DOI] [PubMed] [Google Scholar]
  • 29.Wilson AG, Symons JA, McDowell TL, et al. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci. 1994;94:3195–3199. doi: 10.1073/pnas.94.7.3195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Czaja AJ, Cookson S, Constantini PK, et al. Cytokine polymorphisms associated with clinical features and treatment outcome in type 1 autoimmune hepatitis. Gastroenterology. 1999;117:645–652. doi: 10.1016/S0016-5085(99)70458-0. [DOI] [PubMed] [Google Scholar]
  • 31.Knight JC, Udalova I, Hill AV, et al. A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat Genet. 1999;22:145–150. doi: 10.1038/9649. [DOI] [PubMed] [Google Scholar]
  • 32.Li Kam Wa TC, Mansur AH, Britton J, et al. Association between -308 tumor necrosis factor promoter polymorphism and bronchial hyper reactivity in asthma. Clin Exp Allergy. 1999;29:1204–1208. doi: 10.1046/j.1365-2222.1999.00638.x. [DOI] [PubMed] [Google Scholar]
  • 33.Mira JP, Cariou A, Grall F, et al. Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA. 1999;282:561–568. doi: 10.1001/jama.282.6.561. [DOI] [PubMed] [Google Scholar]
  • 34.Rood MJ, van Krugten MV, Zanelli E, et al. TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematous. Arthritis Rheum. 2000;43:129–134. doi: 10.1002/1529-0131(200001)43:1&#x0003c;129::AID-ANR16&#x0003e;3.0.CO;2-S. [DOI] [PubMed] [Google Scholar]
  • 35.MacDonald PN, Dowd DR, Haussler MR. New insight into the structure and functions of the vitamin D receptor. Semin Nephrol. 1994;14:101–118. [PubMed] [Google Scholar]
  • 36.Gennari L, Becherini L, Masi L, et al. Vitamin D receptor genotypes and intestinal calcium absorption in postmenopausal women. Calcified tissue Int. 1997;61:460–463. doi: 10.1007/s002239900368. [DOI] [PubMed] [Google Scholar]
  • 37.Bellamy R, Ruwende C, Corrah T, et al. Tuberculosis and chronic hepatitis virus infection in Africans and variation in the vitamin D receptor gene. J Infect Dis. 1999;179:721–724. doi: 10.1086/314614. [DOI] [PubMed] [Google Scholar]
  • 38.Roy S, Frodsham A, Saha B, et al. Association of vitamin D receptor genotype with leprosy type. J Infect Dis. 1999;179:187–191. doi: 10.1086/314536. [DOI] [PubMed] [Google Scholar]
  • 39.Jiang XM, Arepally G, Poncz M, et al. Rapid detection of the Fc gamma RIIA-H/R 131 ligand-binding polymorphism using an allele-specific restriction enzyme digestion (ASRED) J Immunol Methods. 1996;199:55–59. doi: 10.1016/S0022-1759(96)00164-0. [DOI] [PubMed] [Google Scholar]
  • 40.Wilson AG, di Giovine FS, Blakemore AI, et al. Single base polymorphism in the human tumor necrosis factor alpha (TNF alpha) gene detectable by Ncol restriction of PCR product. Hum Mol Genet. 1992;1:353. doi: 10.1093/hmg/1.5.353. [DOI] [PubMed] [Google Scholar]
  • 41.Hennig BJW, Parkhill JM, Chapple ILC, et al. Association of a vitamin D receptor gene polymorphism with localized early-onset periodontal diseases. J Periodontol. 1999;70:1032–1038. doi: 10.1902/jop.1999.70.9.1032. [DOI] [PubMed] [Google Scholar]
  • 42.Stur E, Silveira NA, Selvatici LS, et al. Polymorphism Analysis of MTHFR, Factor II and Factor V genes in the Pomeranian population of Espirito Santo-Brazil. Genet Test Mol Biomarkers. 2012;16:219–222. doi: 10.1089/gtmb.2011.0163. [DOI] [PubMed] [Google Scholar]
  • 43.Wang L, Chen R-F, Liu J-W, et al. DC-SIGN (CD209) Promoter 2336 A/G Polymorphism Is Associated with Dengue Hemorrhagic Fever and Correlated to DC-SIGN Expression and Immune Augmentation. PLoS Negl Trop Dis. 2011;5:e934. doi: 10.1371/journal.pntd.0000934. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Kashima S, Rodrigues ES, Azevedo R, et al. DC-SIGN (CD209) gene promoter polymorphisms in a Brazilian population and their association with human T-cell lymphotropic virus type 1 infection. J Gen Virol. 2009;90:927–934. doi: 10.1099/vir.0.008367-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Lehrnbecher T, Foster CB, Zhu S, et al. Variant genotypes of the low affinity Fc gamma Receptors in two control populations and a review of low affinity receptor polymorphisms in control and disease population. Blood. 1999;94:4220–4232. [PubMed] [Google Scholar]
  • 46.Witte JS, Palmer LJ, O’Connor RD, et al. Relation between tumor necrosis factor polymorphism TNFa-308 and risk of asthma. Eur J Hum Genet. 2002;10:82–85. doi: 10.1038/sj.ejhg.5200746. [DOI] [PubMed] [Google Scholar]
  • 47.Moreira PR, Costa JE, Gomez RS, et al. TNFA and IL10 gene polymorphisms are not associated with periodontitis in brazilians. Open Dent J. 2009;3:184–190. doi: 10.2174/1874210600903010184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Bhanushali AA, Laipal N, Kulkarni SS, et al. Frequency of fokI and taqI polymorphism of vitamin D receptor gene in Indian population and its association with 25 hydroxyvitamin D levels. Indian J Hum Genet. 2009;15:108–113. doi: 10.4103/0971-6866.60186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Bezerra FF, Cabello GMK, Mendonça LMC, et al. Bone mass and breast milk calcium concentration are associated with vitamin D. J Nutr. 2008;138:277–281. doi: 10.1093/jn/138.2.277. [DOI] [PubMed] [Google Scholar]

Articles from Molecular Biology Reports are provided here courtesy of Nature Publishing Group

RESOURCES